Total hip replacement (THR) is indicated for patients with osteoarthritis where conservative treatment has failed. Metal alloys used in THR implants such as cobalt-chromium (CoCr) have been known to cause pro-inflammatory reactions in patients, therefore leading to the need for costly revision surgery. This study therefore aimed to investigate the role of TLR4 in the activation of a human osteoblast model in response to CoCr particles in vitro.

Human osteoblasts (MG-63 cell line) were seeded at a density of 100,000 cells and treated with 0.5, 5, 50mm3 CoCr particles per cell for 24-hours. Trypan blue and the XTT Cell Proliferation Kit II were then used in conjunction with the cells to assess CoCr-induced cytotoxicity. Cells were pre-treated with a commercially available TLR4-specific small molecule inhibitor (CLI-095) for 6 hours. Untreated cells were used as a negative control and lipopolysaccharide (LPS) was used as a positive control. Following treatment the cell supernatant was collected and used for enzyme-linked immunosorbant assay (ELISA) to measure the secretion of interleukin-8 (IL-8), CXCL10, and interleukin-6 (IL-6).

Trypan blue and XTT analysis showed that there was no significant changes to cell viability or proliferation at any dose used of CoCr after 24 hours. There was a significant increase in protein secretion of IL-8 (p<0.001), CXCL10 (p<0.001), and IL-6 (p<0.001) in the cells which received the highest dosage of CoCr. This pro-inflammatory secretory response was ameliorated by TLR4 blockade (p<0.001).

CoCr particles are not cytotoxic to osteoblasts but they do induce pro-inflammatory changes as characterised by increased secretion of chemokines IL-8, CXCL10, and IL-6. These responses occur via a TLR4-mediated pathway and upon inhibition they can be effectively ameliorated. This is particularly important as TLR4 could be a potential target for pharmacological intervention used in patients experiencing immunological reactions to metal implant debris.

Introduction and Objective

Total joint replacement (TJR) is indicated for patients with end-stage osteoarthritis (OA) where conservative treatment has failed. Approximately 1.3 million primary hip replacement surgeries have been recorded in the United Kingdom since 2003 and this number is set to rise due to an increase in obesity as well as an ageing population. Total hip replacement (THR) has a survival rate of 85% at 20 years; the most common reason for failure is aseptic loosening which often occurs secondary to osteolysis caused by immune-mediated inflammation responses to wear debris generated from the materials used in the THR implant. Therefore, by understanding the biological steps by which biomaterials cause immune-mediated reactions it should be possible to prevent them in the future thereby reducing the number of costly revision surgeries required.

Spinal total disc replacement (TDR) designs rely heavily on total hip replacement (THR) technology and it is therefore prudent to check that typical TDR devices have acceptable friction and torque behaviour. For spherical devices friction factor (f) is used in place of friction coefficient (mju). The range of loading for the lumbar spinal discs is estimated at perhaps 3 times body weight (BW) for normal activity rising to up to 6 times BW for strenuous activity^[1]. For walking this equates to around 2000 N, which is the maximum load required by the ISO standard for TDR wear testing^[2].

Three Prodisc-L TDR devices (Synthes Spine) were tested in a single station friction simulator. Bovine serum diluted to 25% was used as a lubricating medium. Flexion-extension was ±5 deg for all experiments with constant axial loading of 500, 2000 and 3000 N. The cycle run length was limited to 100 and the f and torque (T) values recorded around the maximum velocity of the cycle point and averaged over multiple cycles.

Preliminary results shows that the 500 N loading produced the largest f of 0.05 ± 0.004. The 2000 N load, which approximates daily activity, gave f = 0.036 ± 0.05 and the 3000 N load gave f = 0.013 ± 0.003. The trend was for lower f with increasing loads.

A lumbar TDR friction factor of 0.036 for a 2000N load and the reduction in f for increasing loads is comparable to the lower end of the range of values reported for THR in similar simulator studies using metal-on-polyethylene bearing materials^[3]. The 3000 N result showing that increasing the load above that expected in daily activity does not raise the f could be important when considering rotational stability and anchorage in a TDR device because frictional torque at the bearing surfaces is proportional to the product of load, device radius and f.

Introduction

It is believed that wear of replacement joints vivo in is strongly dependent on input motions (kinematics) and loading. There is difficulty in accurately measuring total disc replacement (TDR) kinematics in vivo. It is therefore desirable to ascertain the sensitivity of implant wear in vitro to perturbations of the standard testing parameters. An anterior-posterior (AP) shear force input is not currently included in the present ISO and ASTM testing standards for lumbar TDRs but is known to exist in in vivo. Other joint-replacement wear tests have shown that the phasing of input motions influences the ‘cross-shear’ process of polyethylene wear. Polyethylene bearing materials do not behave linearly to axial loading changes and so the effect on wear rate is difficult to predict. The study aim was to assess the effects on wear of a ProDisc-L TDR under the following conditions: ISO 18191-1 standard inputs; an additional input AP shear; input kinematics phasing changes; axial loading changes.